BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16011534)

  • 1. Incidence of and risk factors for tenofovir-induced nephrotoxicity: a retrospective cohort study.
    Antoniou T; Raboud J; Chirhin S; Yoong D; Govan V; Gough K; Rachlis A; Loutfy M
    HIV Med; 2005 Jul; 6(4):284-90. PubMed ID: 16011534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of hypophosphataemia in tenofovir disoproxil fumarate (TDF)-exposed and TDF-unexposed HIV-infected out-patients receiving highly active antiretroviral therapy.
    Buchacz K; Brooks JT; Tong T; Moorman AC; Baker RK; Holmberg SD; Greenberg A;
    HIV Med; 2006 Oct; 7(7):451-6. PubMed ID: 16925731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal function in antiretroviral-experienced patients treated with tenofovir disoproxil fumarate associated with atazanavir/ritonavir.
    Gérard L; Chazallon C; Taburet AM; Girard PM; Aboulker JP; Piketty C
    Antivir Ther; 2007; 12(1):31-9. PubMed ID: 17503745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term renal safety of tenofovir disoproxil fumarate in antiretroviral-naive HIV-1-infected patients. Data from a double-blind randomized active-controlled multicentre study.
    Izzedine H; Hulot JS; Vittecoq D; Gallant JE; Staszewski S; Launay-Vacher V; Cheng A; Deray G;
    Nephrol Dial Transplant; 2005 Apr; 20(4):743-6. PubMed ID: 15741212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal changes in renal glomerular function associated with the use of Tenofovir Disoproxil Fumarate in HIV-infected Nigerians.
    Agbaji OO; Agaba PA; Idoko JA; Taiwo B; Murphy R; Kanki P; Ekong E
    West Afr J Med; 2011; 30(3):164-8. PubMed ID: 22120479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minor changes in calculated creatinine clearance and anion-gap are associated with tenofovir disoproxil fumarate-containing highly active antiretroviral therapy.
    Winston A; Amin J; Mallon P; Marriott D; Carr A; Cooper DA; Emery S
    HIV Med; 2006 Mar; 7(2):105-11. PubMed ID: 16420255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is tenofovir involved in hypophosphatemia and decrease of tubular phosphate reabsorption in HIV-positive adults?
    Badiou S; De Boever CM; Terrier N; Baillat V; Cristol JP; Reynes J
    J Infect; 2006 May; 52(5):335-8. PubMed ID: 16176835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subclinical tubular injury in HIV-infected individuals on antiretroviral therapy: a cross-sectional analysis.
    Hall AM; Edwards SG; Lapsley M; Connolly JO; Chetty K; O'Farrell S; Unwin RJ; Williams IG
    Am J Kidney Dis; 2009 Dec; 54(6):1034-42. PubMed ID: 19783343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal safety of tenofovir disoproxil fumarate.
    Sax PE; Gallant JE; Klotman PE
    AIDS Read; 2007 Feb; 17(2):90-2, 99-104, C3. PubMed ID: 17323508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amprenavir and didanosine are associated with declining kidney function among patients receiving tenofovir.
    Crane HM; Kestenbaum B; Harrington RD; Kitahata MM
    AIDS; 2007 Jul; 21(11):1431-9. PubMed ID: 17589189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in renal function associated with tenofovir disoproxil fumarate treatment, compared with nucleoside reverse-transcriptase inhibitor treatment.
    Gallant JE; Parish MA; Keruly JC; Moore RD
    Clin Infect Dis; 2005 Apr; 40(8):1194-8. PubMed ID: 15791522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute renal failure after initiation of tenofovir disoproxil fumarate.
    Hynes P; Urbina A; McMeeking A; Barisoni L; Rabenou R
    Ren Fail; 2007; 29(8):1063-6. PubMed ID: 18067059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tenofovir use is associated with an increase in serum alkaline phosphatase in the Swiss HIV Cohort Study.
    Fux CA; Rauch A; Simcock M; Bucher HC; Hirschel B; Opravil M; Vernazza P; Cavassini M; Bernasconi E; Elzi L; Furrer H;
    Antivir Ther; 2008; 13(8):1077-82. PubMed ID: 19195333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse effects of tenofovir use in HIV-infected pregnant women and their infants.
    Nurutdinova D; Onen NF; Hayes E; Mondy K; Overton ET
    Ann Pharmacother; 2008 Nov; 42(11):1581-5. PubMed ID: 18957630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective study of renal function in HIV-infected pediatric patients receiving tenofovir-containing HAART regimens.
    Soler-Palacín P; Melendo S; Noguera-Julian A; Fortuny C; Navarro ML; Mellado MJ; Garcia L; Uriona S; Martín-Nalda A; Figueras C
    AIDS; 2011 Jan; 25(2):171-6. PubMed ID: 21076275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal impairment in HIV-1 infected patients receiving antiretroviral regimens including tenofovir in a resource-limited setting.
    Manosuthi W; Prasithsirikul W; Tantanathip P; Chimsuntorn S; Nilkamhang S; Sungkanuparph S
    Southeast Asian J Trop Med Public Health; 2011 May; 42(3):643-50. PubMed ID: 21706942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort Study.
    Fux CA; Simcock M; Wolbers M; Bucher HC; Hirschel B; Opravil M; Vernazza P; Cavassini M; Bernasconi E; Elzi L; Furrer H;
    Antivir Ther; 2007; 12(8):1165-73. PubMed ID: 18240857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with the emergence of K65R in patients with HIV-1 infection treated with combination antiretroviral therapy containing tenofovir.
    von Wyl V; Yerly S; Böni J; Bürgisser P; Klimkait T; Battegay M; Bernasconi E; Cavassini M; Furrer H; Hirschel B; Vernazza PL; Rickenbach M; Ledergerber B; Günthard HF;
    Clin Infect Dis; 2008 Apr; 46(8):1299-309. PubMed ID: 18444871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patients.
    Benhamou Y; Fleury H; Trimoulet P; Pellegrin I; Urbinelli R; Katlama C; Rozenbaum W; Le Teuff G; Trylesinski A; Piketty C;
    Hepatology; 2006 Mar; 43(3):548-55. PubMed ID: 16496322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia.
    Jeffres MN; Isakow W; Doherty JA; Micek ST; Kollef MH
    Clin Ther; 2007 Jun; 29(6):1107-15. PubMed ID: 17692725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.